Report 2018
Rethink Tomorrow
Report 2018

Cash flow

Cash flow from operating activities

Cash flow from operating activities was DKK 3,679 million, down from DKK 4,063 million in 2017. Higher net profit impacted cash flow positively, while higher net working capitalAll current assets less current liabilities used in, or necessary for, the company’s operations. The main components are inventories, trade receivables and trade payables. negatively impacted cash flow by DKK 847 million. The development in net working capital was caused by higher receivables and increasing inventories, as well as lower deferred income and contract liabilities.

 

Net investments

Net investments excluding acquisitions were DKK 1,388 million, down from DKK 1,665 million in 2017. Net investments in property, plant and equipment amounted to DKK 1,328 million, compared with DKK 1,566 million in 2017. Novozymes' main investment projects in 2018 were the greenfield facility in Mumbai, India, the capacity expansion in Nebraska, US, and the innovation campus in Lyngby, Denmark.

 

Free cash flow before acquisitions

Free cash flow before net acquisitionsCash flow from operating activities minus cash flow from investing activities and changes in net working capital, business acquisitions, divestments and purchase of financial assets. was DKK 2,291 million, compared with DKK 2,398 million in 2017. The decrease of 4% was mainly due to higher net working capital, offset by lower net investments and to some extent also higher net profit.

 

Free cash flow

Free cash flow was DKK 2,287 million in 2018, compared with DKK 2,395 million in 2017.

 

Financing activities

Cash flow from financing activities was negative at DKK 2,167 million, compared with a negative cash flow of DKK 2,553 million in 2017. The negative cash flow from financing activities was mainly due to completion of the stock buyback program (DKK 2,000 million) and dividend payments (DKK 1,317 million).

 

Cash position

Cash and cash equivalents at December 31, 2018, amounted to DKK 723 million, up from DKK 632 million at December 31, 2017. Undrawn committed credit facilities were DKK 3,646 million at December 31, 2018.

 

DKK million Note 2018 2017
Net profit 3,227 3,120
Reversal of non-cash items 6.6 2,062 2,065
Income tax paid 2.6 (761) (852)
Interest received 9 7
Interest paid (11) (28)
Cash flow before change in working capital 4,526 4,312
Change in working capital
(Increase)/decrease in receivables (361) (96)
(Increase)/decrease in inventories (234) (224)
Increase/(decrease) in payables, deferred income and contract liabilities (265) 74
Currency translation adjustments 13 (3)
Cash flow from operating activities 3,679 4,063
Investments
Purchase of intangible assets 3.1 (60) (99)
Purchase of property, plant and equipment (1,332) (1,593)
Sale of property, plant and equipment 4 27
Business acquisitions, divestments and purchase of financial assets 6.6 (4) (3)
Cash flow from investing activities (1,392) (1,668)
Free cash flow 2,287 2,395
DKK million Note 2018 2017
Financing
Borrowings 2,093 965
Repayments of borrowings (1,115) (505)
Purchase of treasury stock (2,000) (2,000)
Sale of treasury stock 172 179
Dividend paid (1,317) (1,192)
Cash flow from financing activities (2,167) (2,553)
Net cash flow 120 (158)
Unrealized gain/(loss) on currencies and financial assets included in cash and cash equivalents (29) (22)
Net change in cash and cash equivalents 91 (180)
Cash and cash equivalents at January 1 632 812
Cash and cash equivalents at December 31 723 632
Cash flow from operating activities
DKK million
Net investments
DKK million * Excluding acquisitions and The BioAg Alliance impact in 2014. %
  • Net investments 
  • Net investments (% of sales)
Free cash flow before acquisitions
DKK million * 2014 net impact of The BioAg Alliance DKK ~1,700 million.
Back to notes
Scroll to top